Augmented expression of urokinase plasminogen activator and extracellular matrix proteins associates with multiple myeloma progression

• Published in: Clinical & experimental metastasis Vol. 31; no. 5; pp. 585 - 593
• Main Authors: Khan, Rehan, Gupta, Nidhi, Kumar, Raman, Sharma, Manoj, Kumar, Lalit, Sharma, Alpana
• Format: Journal Article
• Language: English
• Published: Dordrecht Springer Netherlands 01.06.2014; Springer Nature B.V
• Subjects: Adult; Aged; Biomedical and Life Sciences; Biomedicine; Cancer Research; Case-Control Studies; Disease Progression; Extracellular Matrix Proteins - blood; Extracellular Matrix Proteins - genetics; Extracellular Matrix Proteins - metabolism; Female; Gene Expression Regulation, Neoplastic; Hematology; Humans; Male; Middle Aged; Multiple Myeloma - genetics; Multiple Myeloma - metabolism; Multiple Myeloma - pathology; Neoplasm Staging; Oncology; Research Paper; RNA, Messenger - genetics; RNA, Messenger - metabolism; Surgical Oncology; Urokinase-Type Plasminogen Activator - blood; Urokinase-Type Plasminogen Activator - genetics; Urokinase-Type Plasminogen Activator - metabolism; Nidogen; ECM proteins; uPA; Multiple Myeloma; Basement membrane
• ISSN: 0262-0898; 1573-7276; 1573-7276
• DOI: 10.1007/s10585-014-9652-7

Multiple myeloma (MM) represents a B cell malignancy, characterized by a monoclonal proliferation of malignant plasma cells. Interactions between tumor cells and extracellular matrix (ECM) are of importance for tumor invasion and metastasis. Protein levels of urokinase plasminogen activator (uPA) and fibulin 1, nidogen and laminin in plasma and serum respectively and mRNA levels of these molecules in peripheral blood mononuclear cells were determined in 80 subjects by using ELISA and quantitative PCR and data was analyzed with severity of disease. Pearson correlation was determined to observe interrelationship between different molecules. A statistical significant increase for ECM proteins (laminin, nidogen and fibulin 1) and uPA at circulatory level as well as at mRNA level was observed compared to healthy controls. The levels of these molecules in serum might be utilized as a marker of active disease. Significant positive correlation of all ECM proteins with uPA was found and data also correlates with severity of disease. Strong association found between ECM proteins and uPA in this study supports that there might be interplay between these molecules which can be targeted. This study on these molecules may help to gain insight into processes of growth, spread, and clinical behavior of MM.